Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of treatment center characteristics on early death rates in patients with newly diagnosed acute promyelocytic leukemia: Analysis of data from the SEER program
    Meeting Abstract

    Park, J. H.; Devlin, S.; Lynch, C.; Schwartz, A.; Keegan, T.; Gonsalves, L.; Hermit, K.; Green, M.; Douer, D.; Tallman, M. S.
    Blood (2016)

    Fulltext@MSK | Save
  • Ponatinib in chronic-phase chronic myeloid leukemia patients: Final report from a phase 1 trial
    Meeting Abstract

    Mauro, M. J.; Cortes, J. E.; Kantarjian, H. M.; Shah, N. P.; Bixby, D. L.; Flinn, I. W.; O'Hare, T.; Rivera, V. M.; Lustgarten, S.; Santillana, S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Predictors of ponatinib therapy duration among real-world chronic phase chronic myeloid leukemia (CP-CML) patients in the US
    Meeting Abstract

    Mauro, M. J.; McGarry, L. J.; Lustgarten, S.; Huang, H.
    Blood (2016)

    Fulltext@MSK | Save
  • CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes through cytokine feed forward mechanisms
    Meeting Abstract

    Mathias, M. D.; Sockolosky, J. T.; Chang, A. Y. Y.; Liu, C.; Garcia, K. C.; Scheinberg, D. A.
    Blood (2016)

    Fulltext@MSK | Save
  • The development of a qPCR assay for the evaluation of the dendritic cell chimeric antigen receptor transcriptome
    Meeting Abstract

    Leyfman, Y.; Daniyan, A.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • Treatment-related infections and risk factors in patients with myeloproliferative neoplasms treated with ruxolitinib
    Meeting Abstract

    King, A. C.; Hsu, M.; Mauro, M. J.; Rampal, R. K.
    Blood (2016)

    Fulltext@MSK | Save
  • Long-term follow-up of the efficacy and safety of ponatinib in Philadelphia chromosome-positive leukemia patients with the T315I mutation
    Meeting Abstract

    Jabbour, E. J.; Cortes, J. E.; Talpaz, M.; Baccarani, M.; Mauro, M. J.; Hochhaus, A.; Hughes, T. P.; Guilhot, F.; Deininger, M. W.; Shah, N.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Phase I trial of targeted alpha-particle therapy with Actinium-225 ((225)Ac)-lintuzumab and low-dose cytarabine (LDAC) in patients age 60 or older with untreated acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Levy, M. Y.; Park, J. H.; Ravandi, F.; Perl, A. E.; Pagel, J. M.; Smith, B. D.; Estey, E. H.; Kantarjian, H.; Cicic, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplant with ablative conditioning is associated with favorable outcomes in patients with mixed phenotype acute leukemia
    Meeting Abstract

    Getta, B. M.; Zheng, J. T.; Tallman, M. S.; Park, J. H.; Stein, E. M.; Roshal, M.; Papadopoulos, E. B.; Kernan, N. A.; Steinherz, P. G.; O'Reilly, R. J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Clinical relevant alterations identified by comprehensive genomic profiling can potentially improve therapeutic option and change prognosis in hematologic malignancies
    Meeting Abstract

    He, J.; Patel, M.; Phillip, I.; Bailey, M.; Berman, E.; Park, J. H.; Shukla, N. N.; Chung, S. S.; Castro-Malaspina, H.; Douer, D.; more...
    Blood (2016)

    Fulltext@MSK | Save